Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DoD/VA Allegra Price Is One-Third Of AWP; Joint Procurement Expands

Executive Summary

The Departments of Defense and Veterans Affairs have awarded a joint national procurement contract to Aventis' Allegra (fexofenadine) for approximately one-third the average wholesale price.

You may also be interested in...



VA/DoD Guidelines Suggest PPIs, H2-Antagonists Work Equally Well For GERD

H2-antagonists and proton pump inhibitors work equally well for the initial treatment of gastroesophageal reflux disease, a 1draft guideline on clinical practice from the Departments of Defense and Veterans Affairs states

VA/DoD Guidelines Suggest PPIs, H2-Antagonists Work Equally Well For GERD

H2-antagonists and proton pump inhibitors work equally well for the initial treatment of gastroesophageal reflux disease, a 1draft guideline on clinical practice from the Departments of Defense and Veterans Affairs states

DoD TRICARE Looking At PBMs To Negotiate Drug Pricing Contracts

The Department of Defense expects to decide within the next three months whether it will turn to a private pharmacy benefit management company to negotiate pharmaceutical contracts for its TRICARE health plan

Related Content

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel